Through the proteomic and genomic screens, we found that DGKA and its metabolic product PA enhanced the formation of cJUN and JNK complex, increased the cJUN phosphorylation level, and thus promoted their nuclear localization, which eventually leads to the high transcriptional activity of cJUN in ovarian cancer cells upon cisplatin exposure. The gene discussed is JUN; the disease is ovarian carcinoma.